A new sesquiterpene lactone and a new aromatic glycoside from Illicium difengpi  by Fang, Lei et al.
Chinese Pharmaceutical AssociationInstitute of Materia Medica, Chinese Academy of Medical Sciences
Acta Pharmaceutica Sinica B
Acta Pharmaceutica Sinica B 2011;1(3):178–1832211-3835 & 2011 In
hosting by Elsevier B
Peer review under re
doi:10.1016/j.apsb.20
nCorresponding au
E-mail address: ywww.elsevier.com/locate/apsb
www.sciencedirect.comORIGINAL ARTICLE
A new sesquiterpene lactone and a new aromatic glycoside
from Illicium difengpiLei Fanga,b, Xiao-jing Wanga, Shuang-gang Maa, Shi-shan Yua,naState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica,
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
bShandong Analysis and Test Center, Shandong Academy of Sciences, Jinan 250014, China
Received 30 May 2011; revised 20 June 2011; accepted 4 August 2011KEY WORDS
Illicium difengpi;
Sesquiterpene lactone;
Aromatic glycoside;
Mosher’s method;
Anti-inﬂammatory
activitiesstitute of Materia M
.V. All rights rese
sponsibility of Inst
11.08.002
thor. Tel.: þ86 10
ushishan@imm.acAbstract A new sesquiterpene lactone (1) and a new aromatic glycoside (2), together with three
known compounds (3–5) were isolated from the stem bark of Illicium difengpi K. I. B et K. I. M.
Their structures were determined by spectroscopic methods, including 1D and 2D NMR,
HRESIMS, and chemical methods. The absolute conﬁguration of the secondary alcohol in 1
was conﬁrmed by Mosher’s method. Compound 2 exhibited signiﬁcant anti-inﬂammatory activity
with IC50 value of 6.72 mmol/L.
& 2011 Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical
Association. Production and hosting by Elsevier B.V. All rights reserved.edica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association. Production and
rved.
itute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association.
63165326; fax: þ86 10 63017757.
.cn (Shi-shan Yu).
A new sesquiterpene lactone and a new aromatic glycoside from I. difengpi 1791. Introduction
The genus Illicium is known to be characterized by prezizaane
sesquiterpene lactones, prenylated C6–C3 compounds, aromatic
glycosides and neolignans1–12. Prezizaane sesquiterpene lactones
are considered to be characteristic constituents of the genus
Illicium, some of which are found to exhibit diverse biological
activities including neurotoxic and neurotrophic effects13,14.
Illicium difengpi K. I. B et K. I. M. (Illiciaceae) is a toxic shrub
indigenous to China and grows in the mountainous areas of
Guangxi Province. The stem bark has been applied as a
traditional Chinese medicine for the treatment of rheumatic
arthritis, and is listed in Pharmacopeia of the People’ Republic of
China. Our previous investigation on the chemical constituents of
this plant has led to the isolation of nine new neolignans and two
new aromatic glycosides15. In continuation, a new sesquiterpene
lactone, difengpilactone (1), a new aromatic glycoside, 4-O-
(glycer-2-yl)-dihydroconiferylalcohol-10-O-b-D-mannopyranoside
(2), together with three known compounds, anislactone A (3),
oligandrumin D (4), and 11-O-debenzoyl-11a-O-2-methyl-cyclo-
pent-1-enecarboxyltashironin (5) were obtained from the stem
bark of the plant. In this paper, the isolation and structural
elucidation of two new and three known compounds, and their
anti-inﬂammatory activities are presented.2. Results and discussion
Compound 1 was obtained as a white amorphous powder with
[a]20Dþ85.0 (c 0.10, MeOH). The UV spectrum showed a
maximum absorption band at 245 nm. Its molecular formula
C16H22O6 was determined by HRESIMS (m/z 311.1495
[MþH]þ, calcd for 311.1489), with requiring six degrees of
unsaturation. The IR spectrum exhibited the presence ofTable 1 1H and 13C NMR data of compounds 1 a
No. 1 (Chloroform-d3)
dH (J in Hz) dC
1 173.6
2 58.0
3 199.0
4 3.30 (s) 29.0
5 133.0
6 176.6
7 53.7
8 4.47 (d, J¼10.0) 72.8
4.04 (d, J¼10.0)
9 1.39 (s) 14.0
10 1.30 (s) 18.7
11 170.0
12 2.68 (dt, J¼11.5, 4.5) 24.1
2.50 (dt, J¼11.5, 4.5)
13 1.71 (m) 37.5
1.57 (m) 67.5
14 3.86 (m)
15 1.25 (d, J¼6.5) 23.8
OCH3 3.68 (s) 52.3
aNMR data were measured in chloroform-d3 and met
carbon.hydroxyl (3420 cm1) and carbonyl functions, including ester
carbonyl (1773 cm1), ketone carbonyl (1735 cm1), and a, b-
conjugated carbonyl (1710 cm1) groups. The 1H NMR spec-
trum (Table 1) showed the signals of three methyl [dH 1.39 (3H,
s, H3-9), 1.30 (3H, s, H3-10) and 1.25 (3H, d, J¼6.5 Hz, H3-
15)], four methylene [dH 3.30 (2H, s, H2-4), 2.68 (1H, dt, J¼4.5,
11.5 Hz, H-12a), 2.50 (1H, dt, J¼4.5, 11.5 Hz, H-12b), 1.71
(1H, m, H-13a), 1.57 (1H, m, H-13b), 4.47 (1H, d, J¼10.0 Hz,
H-8a), 4.04 (1H, d, J¼10.0 Hz, H-8b)], one oxygenated
methine [dH 3.86 (1H, m, H-14)], and one methoxyl [dH 3.68
(3H, s)] groups. The 13C NMR and DEPT spectra (Table 1)
exhibited 16 resonances including four methyl, four methylene,
one methane and seven quaternary carbons. The resonances at
dC 199.0, 176.6, and 173.6 indicated the presence of three
carbonyl groups. The presence of one oleﬁnic functionality was
also indicated by the resonances at dC 133.0 and 170.0. Based
on the above data, compound 1 was determined as a sesqui-
terpene lactone with two rings.
Detailed analyses of the 1D and 2D NMR spectra indicated
the structure of 1 (Fig. 1) and allowed assignment of all proton
and carbon signals. HMBC correlations from H2-8 to C-1 and
C-2, from H3-10 to C-2 and C-8, and from H3-9 to C-1 and
C-7 are indicative of a ﬁve-member lactone ring with two methyl
groups located at C-2 and C-7. The HMBC correlations from
H2-4 to C-2, C-5 and C-6, from H3-9 to C-3 and C-7, as well as
from H3-10 to C-2 and C-6, indicated a cyclohexane-1,4-dione
moiety, which was deduced to be fused at C-2 and C-7. This
conclusion was further conﬁrmed by the key long-range correla-
tions of H2-8/C-6 and H3-9/C-3. The unit of oleﬁnic functionality
was placed at C-5 according to the HMBC correlations from
H2-12 to C-5 and from H2-4 to C-11. Correlations in the
1H–1H COSY and HSQC spectra of 1 indicated the presence
of CH2(12)–CH2(13)–CH(14)–CH3(15) unit (Fig. 2), and the
location of which was conﬁrmed to be at C-11 by HMBCnd 2.a
No. 2 (Methanol-d4)
dH (J in Hz) dC
1 138.7
2 6.79 (s) 114.4
3 152.2
4 146.8
5 6.96 (dd, J¼8.0, 3.0) 119.8
6 6.67 (d, J¼8.0) 122.1
7 2.57 (t, J¼7.5) 33.0
8 1.76 (m) 35.9
9 3.50 (t, J¼6.0) 62.5
10 3.71–3.82 (overlapped) 63.0
20 4.27 (m) 81.6
30 3.71–3.82 (overlapped) 62.5
100 4.25 (d, J¼7.0 ) 105.0
200 3.20–3.31 (overlapped) 71.9
300 3.14 (m) 75.4
400 4.02 (m) 69.2
500 3.20–3.31 (overlapped) 78.2
600 3.71–3.82 (overlapped) 62.4
OCH3 3.78 (s) 56.7
hanol-d4 at 500 MHz for proton and 125 MHz for
OCH 3
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Figure 1 Structures of compounds 1–5.
O
O
OO
O
OH
HO
OCH3
O
OHO
O
HO
HO
OHHO
1 2
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Figure 3 Results with the Mosher’s method (DdH¼dSdR).
Lei Fang et al.180correlations from H2-12 to C-5 and H2-13 to C-11. The methoxyl
unit was placed at C-11 on basis of an HMBC correlation
between H3-16 and C-11.
The relative conﬁgurations for H3-9 and H3-10 were
determined to be cis, on the basis of the NOE correlations
between H3-9 and H3-10 in the NOE experiments. The
absolute conﬁguration at C-14 in 1 was assigned using a
modiﬁed Mosher’s method16 (Fig. 3). The difference in
chemical shifts values of the diastereomeric esters, (S)-MTPA
(1a) and (R)-MTPA (1b), indicated the absolution conﬁgura-
tion of C-14 was S. Hence, the structure of 1 was elucidated as
shown in Fig. 1, and named as difengpilactone.
Compound 2 was obtained as a white amorphous powder.
Its molecular formula was determined as C19H30O10 by the
HRESIMS at m/z 441.1743 [MþNa]þ. The 1H and 13C NMR
spectra of 2 (Table 1) were similar to those of 4-O-(glycer-2-
yl)-dihydroconiferyl alcohol4, except for the presence of a
sugar unit. The sugar moiety was identiﬁed as mannosyl group
on the basis of the characteristic 1H and 13C NMR data.
The b-conﬁguration of the mannosyl group was proved by
the coupling constant (J¼7.0 Hz) for the anomeric proton
[dH 4.25 (1H, d)] while the D-form was conﬁrmed by GCanalysis17. The HMBC correlation from H-100 to C-10 sug-
gested that the b-D-mannose moiety was attached at C-10 of
the aglycone. As a result, the structure of compound 2 was
determined to be 4-O-(glycer-2-yl)-dihydroconiferyl alcohol-
10-O-b-D-mannopyranoside.
Three known compounds, anislactone A (3)18, oligandru-
min D (4)19, and 11-O-debenzoyl-11a-O-2-methyl-cyclopent-1-
enecarboxyltashironin (5)20 were identiﬁed by comparison of
their physical and spectral data with reported values.
The anti-inﬂammatory activities of 1–5 were evaluated by
measuring the inhibitory ratios of b-glucuronidase release in
rat polymorphonuclear leukocytes (PMNs) induced by plate-
let-activating factor (PAF) in vitro21. Compound 2 exhibited
signiﬁcant anti-inﬂammatory activity with IC50 value of
6.72 mmol/L, while the other compounds were inactive. Gink-
golide B was used as a positive control with IC50 value of
2.35 mmol/L.3. Experimental section
3.1. General experimental procedures
Optical rotations were measured on a P2000 automatic digital
polarimeter. UV spectra were taken with a Hitachi UV-240
spectrophotometer. IR spectra were recorded on a Nicolet
5700 FT-IR spectrometer. NMR spectra were recorded on an
Inova 500 MHz spectrometer. GC data were recorded on an
A new sesquiterpene lactone and a new aromatic glycoside from I. difengpi 181Agilent N6890 instrument. ESIMS data were obtained on a
Q-Trap LC/MS/MS (Turbo Ionspray Source) spectrometer.
HRESIMS were measured on an Agilent Technologies 6250
Accurate-Mass Q-TOF LC/MS. Preparative HPLC was car-
ried out on a Shimadzu LC-6AD instrument with a SPD-10A
detector using a YMC-Pack ODS-A column (250 mm 20
mm, 5 mm). Analytical HPLC was measured on an Agilent
1100 Series instrument with a DAD detector using a YMC
Rp-18 column (100 mm 4.6 mm). Column chromatography
was performed with Sephadex LH-20 (Amersham Pharmacia
Biotech AB, Sweden), Rp-18 (50 mm, Merck), and silica gel
(200–300 mesh, Qingdao Marine Chemical Inc., China). TLC
was carried out with glass precoated with silica gel GF254
(Qingdao Marine Chemical Inc., China).
3.2. Plant material
The stem bark of I. difengpi (20 kg) was purchased from
Tongrentang Pharmacy, Beijing, China, in September 2007,
and identiﬁed by Prof. Lin Ma (Department of Natural
Products Chemistry, Institute of Materia Medica, Chinese
Academy of Medical Sciences). A voucher specimen (No.
20070922) is deposited in the Herbarium of the Department of
Medicinal Plants, Institute of Materia Medica, Chinese Academy
of Medical Sciences, P.R. China.Table 2 1H and 13C NMR data of compounds 3, 4
No. 3 4
dH (J in Hz) dC dH (J in Hz)
1 96.3
2 1.58 (m) 38.0
1.86 (m)
3 1.94 (m) 35.7 1.76 (m)
2.05 (m) 2.14 (m)
4 90.6 1.84 (m)
2.11 (m)
5 56.5
6 61.2
7 5.11 (s) 82.1
8 0.97 (s) 15.2
9 67.3 2.43 (d, J¼1
2.97 (d, J¼1
10 2.75 (d, J¼6.5) 37.1
3.78 (d, J¼6.5)
11 174.9 2.40 (d, J¼1
2.90 (d, J¼1
12 178.8
13 0.97 (s) 18.2 2.19 (s)
14 3.80 (d, J¼8.5) 73.9 1.30 (s)
4.25 (d, J¼8.5)
15 1.46 (s) 20.9 41.7 (d, J¼1
4.33 (d, J¼1
10 1.30 (s)
20
30
40
50
60
70
aNMR data were measured in chloroform-d3 at 500 M3.3. Extraction and isolation
The air-dried stem bark of I. difengpi (20 kg) was ground, and
the resultant powder was sequentially extracted with CH2Cl2,
and MeOH to yield 300 g of a CH2Cl2 extract. The crude
CH2Cl2 extract was chromatographed over Rp-18 column and
eluted with a solvent system (80%, 90%, and 100% MeOH–
H2O) to give three fractions Fr.1–Fr.3. The Fr.1 and Fr.2
(44.8 g) were repeatedly subjected to Rp-18 and Sephadex LH-
20 column, and preparative HPLC to afford compounds 1
(15 mg), 3 (25 mg), 4 (18 mg), and 5 (25 mg). The isolation
procedure of the MeOH extract was successive to those
reported previously15. Compound 2 (500 mg) was isolated
from fraction A2-8-3–5 (1.05 g) with preparative HPLC using
a mobile phrase of CH3CN–H2O (15:85).3.4. Structure elucidation
Compound 1: White, amorphous powder; [a]20Dþ85.0 (c 0.10,
MeOH); UV (MeOH) lmax: 245 nm. IR (KBr) nmax 3420,
2973, 1773, 1735, 1710,1643, 1077, and 1021 cm1; ESIMS m/z
311[MþH]þ, 333 [MþNa]þ; HRESIMS m/z 311.1495
[MþH]þ (calcd for C16H23O6, 311.1489); 1H and 13C NMR
data, see Table 1.and 5.a
5
dC dH (J in Hz) dC
2.25 (m) 40.0
96.5 31.1
33.8 33.4
32.6 85.7
85.8 54.2
55.9 60.7
210.6 210.9
172.1 2.13 (d, J¼18.0) 44.1
2.46 (d, J¼18.0)
8.0) 35.1 52.1
8.0)
54.4 3.94 (d, J¼2.0) 76.5
3.0) 35.9 109.4
3.0)
175.0 1.12 (s) 9.8
29.7 1.02 (s) 15.0
18.5 3.80 (d, J¼9.0) 74.3
4.16 (d, J¼9.0)
3.0) 67.6 1.20 (d, J¼7.0) 13.5
3.0)
23.9 165.0
126.4
160.1
2.32 (m) 41.1
1.78 (m) 21.2
2.35 (m) 34.0
2.07 (s) 14.6
Hz for proton and 125 MHz for carbon.
Lei Fang et al.182Compound 2: Amorphous powder; [a]20D 17.0 (c 0.10,
MeOH); UV (MeOH) lmax: 206 and 278 nm; IR (KBr) nmax
3333, 2933, 1604, 1511, 1455, 1264, and 930 cm1; ESIMS m/z
441 [MþNa]þ, 457 [MþK]þ and 417 [M–H]; HRESIMS m/z
441.1743 [MþNa]þ (calcd for C19H30O10, 441.1731); 1H and
13C NMR, see Table 1.
Compound 3: White, amorphous powder. UV (MeOH) lmax:
204 nm. ESIMS m/z 319 [MþNa]þ; 1H and 13C NMR data, see
Table 2. The above data was identical with anislactone A11,
therefore compound 3 was determined as anislactone A.
Compound 4: White, amorphous powder. UV (MeOH) lmax:
204 nm. ESIMS m/z 319 [MþNa]þ; 1H and 13C NMR data, see
Table 2. The above data was identical with oligandrumin D12,
therefore compound 4 was determined as oligandrumin D.
Compound 5:White, amorphous powder. UV (MeOH) lmax:
247 nm. ESIMS m/z 391 [MþH]þ, 413 [MþNa]þ, and 429
[MþK]þ; 1H and 13C NMR data, see Table 2. The above data
was identical with 11-O-debenzoyl-11a-O-2-methyl-cyclopent-
1-enecarboxyltashironin13, therefore compound 5 was
determined as 11-O-debenzoyl-11a-O-2-methyl-cyclopent-1-
enecarboxyltashironin.
3.5. Preparation of (R)- and (S)-MTPA esters from 1
According to the published procedure16, compound 1 is
dissolved in pyridine-d5 in an NMR tube and a calculated
amount of (R)-MTPA chloride is added. Then, the solution
was allowed to stand overnight at room temperature to afford
the (S)-MTPA ester 1a: 1H NMR (500 MHz, pyridine-d5) dH
3.49 (2H, s, H-4), 4.31 (1H, d, J¼10.0 Hz, H-8a), 3.95 (1H, d,
J¼10.0 Hz, H-8b), 1.37 (3H, s, H-9), 1.26 (3H, s, H-10), 2.46
(1H, m, H-12a), 2.39 (1H, m, H-12b), 1.80 (1H, m, H-13a),
1.78 (1H, m, H-13b), 5.17 (1H, m, H-14), 1.35 (3H, d, J¼6.5
Hz, H-15), 3.65 (3H, s, OCH3). The same procedure was
applied to 1 with (S)-MTPA chloride to yield the R-MTPA
ester 1b: 1H NMR (500 MHz, pyridine-d5) dH 3.58 (2H, s, H-
4), 4.20 (1H, d, J¼10.0 Hz, H-8a), 3.86 (1H, d, J¼10.0 Hz, H-
8b), 1.34 (3H, s, H-9), 1.10 (3H, s, H-10), 2.30 (1H, m, H-12a),
2.24 (1H, m, H-12b), 1.78 (1H, m, H-13a), 1.70 (1H, m, H-
13b), 5.17 (1H, m, H-14), 1.40 (3H, d, J¼6.5 Hz, H-15), 3.66
(3H, s, OCH3).
3.6. Acid hydrolysis of compound 2
Compound 2 (10 mg) was dissolved in 5% HCl–H2O (25 mL)
and heated at 90 1C for 10 h. The reaction mixture was diluted
with water and extracted with EtOAc three times (15, 15, and
15 mL). The aqueous layer was evaporated to dryness under
pressure to give a monosaccharide residue. From the residue,
mannose was detected by TLC with authentic samples.
3.7. Absolute conﬁguration of the monosaccharides
The absolute conﬁgurations of the mannose were determined
according to a reported procedure17. Authentic sugar samples
were trimethylsilylated, and the derivatives were analyzed by GC.
3.8. Anti-inﬂammatory activity assays
According to the reported procedures21, the anti-inﬂammatory
activities of compounds 1–5 were assayed by measuring theinhibitory ratio of b-glucuronidase release in rat PMNs
induced by PAF in vitro. Ginkgolide B was used as a positive
control. The absorbance was read at 550 nm and the inhibi-
tory ratio (IR) was calculated.
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